JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB39614

Goat Anti-Mouse IgG H&L (6nm Gold)

Be the first to review this product! Submit a review

|

(4 Publications)

Suitable for EM. Cited in 4 publications.

View Alternative Names

Igh-4, Ighg1, Ig gamma-1 chain C region secreted form, Igh-4, Ighg1

Key facts

Host species

Goat

Target species

Mouse

Target isotype

IgG

Target specificity

Heavy & Light chains

Minimal cross-reactivity
Pre-adsorbed

No

Conjugation

6nm Gold

Excitation/Emission
Applications

EM

applications

Clonality

Polyclonal

Isotype

IgG

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "EM": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

This product is an immunogold reagent built around colloidal gold particles of 6nm. The paritcle population is monodisperse and thus shows minimal size variation and overlap. Typically, the coefficient of variance for the 6nm particle size conjugate is less than 12 %.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
This product has been immuno-affinity purified and immuno cross-absorbed to reduce non-specific reactions.The activity of each lot is determined using a dot-spot test system as described by Moeremans et al., J. Immunol. Methods, 74, (1984), 353.
Storage buffer
Preservative: 0.097% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Product protocols

Target data

See full target information Ighg1

Additional targets

Ighg1

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

The Journal of biological chemistry 301:108396 PubMed40074078

2025

Distinct neuronal vulnerability and metabolic dysfunctions are characteristic features of fast-progressing Alzheimer's patients with Lewy bodies.

Applications

Unspecified application

Species

Unspecified reactive species

Mohammed Waseequr Rahman,Preeti Sharma,Trisha Chattopadhyay,Sivaprakasam R Saroja

iScience 28:111935 PubMed40028275

2025

SENP2-based N-terminal truncation of α-synuclein in Lewy pathology propagation.

Applications

Unspecified application

Species

Unspecified reactive species

Katsutoshi Taguchi,Yoshihisa Watanabe,Masaki Tanaka

Journal of controlled release : official journal of the Controlled Release Society 372:433-445 PubMed38908756

2024

Auto-loaded TRAIL-exosomes derived from induced neural stem cells for brain cancer therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaopei Zhang,Hannah Taylor,Alain Valdivia,Rajaneekar Dasari,Andrew Buckley,Emily Bonacquisti,Juliane Nguyen,Krishna Kanchi,David L Corcoran,Laura E Herring,Dennis A Steindler,Albert Baldwin,Shawn Hingtgen,Andrew Benson Satterlee

PLoS pathogens 17:e1009628 PubMed34061899

2021

The ultrastructure of infectious L-type bovine spongiform encephalopathy prions constrains molecular models.

Applications

Unspecified application

Species

Unspecified reactive species

Razieh Kamali-Jamil,Ester Vázquez-Fernández,Brian Tancowny,Vineet Rathod,Sara Amidian,Xiongyao Wang,Xinli Tang,Andrew Fang,Assunta Senatore,Simone Hornemann,Sandor Dudas,Adriano Aguzzi,Howard S Young,Holger Wille
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com